Jobs
View more job listings or post a job
Bioduro-Sundia Associate Director/Director in Laboratory Animal and Exploratory Toxicology
Variant Bio (Senior) Scientist - DMPK
Alturas Analytics Scientist 1
University of California, Davis TOXICOLOGY ANALYTICAL CHEMIST (STAFF RESEARCH ASSOCIATE 3)
University of California, Davis CALIFORNIA ANIMAL HEALTH AND FOOD SAFETY LABORATORY - TOXICOLOGY LAB RESEARCH SUPERVISOR/GROUP LEADER
Eli Lilly and Company R-39973 Scientific Director ADME - Novel Modalities (Open)
FibroGen Director DMPK
Applied BioMath Technical Marketing Specialist
Post a job

Symposium

[Free Online Webcast] Regenerative Medicine: Latest Advances and Case Studies


Speakers: Peter Santa Maria, MD, PhD, Professor, Stanford University; David Myung, MD, PhD, Professor, Stanford University; John Ramunas, PhD, CEO, Rejuvenation Technologies; Luis Alvarez, PhD, CEO, Theradaptive
Organizers: Peter Staehr and Shichang Miao
Date: 2021-12-06
Time: 8:30-12:40 Pacific Time
Registration fee: (USD):
Location: Online via Zoom
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2021-12-05  (it will close sooner if the seating cap is reached)

About the Topic

Regenerative medicine includes the generation and use of therapeutic stem cells, tissue engineering, and the production of artificial organs. Regrowing, repairing, or replacing damaged or diseased cells, organs or tissues has the potential to tremendously benefit patients and our society as a whole. The mini-symposium intends to give the attendees some insight into these various areas of regenerative medicine.

The speakers will present on the translational development of the tympanic membrane to improve or enable hearing as well as the development of biomaterials for the cornea to improve the vision. What development techniques are available and what challenges must be overcome?

Another presentation provides insights on how to possibly treat fatal diseases of aging. When telomeres become too short, cells can't function, which is the major driver of disease and aging. Using mRNA encoding telomerase (TERT mRNA) has the potential to reverse telomere shortening. 

The development of biomaterials for orthopedic applications is another important area in regenerative medicine. One approach is to deliver therapeutic proteins that enhance healing of implants. Coating the surface of implants with these proteins like paint can make them more readily available for cells of the body to interact with.

Tentative Agenda:

8:30 Am – 8:40 AM: Welcome and Introduction

8:40 AM – 9:30 AM: Engineering protein interfaces to create regenerative implants. Luis Alvarez, PhD, CEO, Theradaptive

9:30 AM – 10:20 AM: Regenerative biomaterials for the cornea. David Myung, MD, PhD, Professor, Stanford University

10:20 AM – 10:30 AM: Break

10:30 AM – 11:20 AM: Telomere extension using TERT mRNA. John Ramunas, PhD, CEO, Rejuvenation Technologies

11:20 AM – 12:10 PM: The translational journey of tympanic membrane regeneration. Peter Santa Maria, MD, PhD, Professor, Stanford University

12:10 PM – 12:40 PM: Panel Discussion

 


2024-05-30, [Free Online Workshop] Career Transition for Research Scientists: Career Overview, Project Management and Regulatory Affairs (jointly with BioPharmaPM and RAPS-SF)
2024-06-13, [In-Person] CMC Strategies and Activities for IND and NDA Filing for Small Molecules: Nuts, Bolts and Best Practices
2024-06-20, Alzheimer's Disease: Untangling What We Thought We Knew and Future Precision Diagnostics and Therapeutics
2024-07-24, [Free Online] The Science and Stories of Promising Biotech Startups: Symposium No.6
2024-08-14, [Free Online] Advances in Cancer Therapeutics
2024-09-10, [In-Person] Translational PK/PD and Human Dose Projections for Antibodies and Novel Therapeutic Modalities: Antibodies, ADCs, Covalent Inhibitors, Ocular and Neuro delivery, Vaccines, Bispecifics, Cell and Gene Therapies
2024-09-20, [In-Person] Non-clinical Safety Assessments of Biologics and Other Novel Modalities for IND/NDA/BLA Filings
2024-09-25, [Free Online] Development of Protein Degraders: Computational Modeling, Medicinal Chemistry and Early Development
2024-10-10, [In-Person] Regulatory Global Submission: Strategies and Best Practices for FDA, EMA and PMDA
┬ęPharmaceutical & BioScience Society, International; Last Modified: 5/29/2024; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Simulations Plus Join us for MIDD+ San Francisco, a free event June 6-7. Hear scientific presentations from industry leaders, train with experts & connect with peers.
Hypha Discovery Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
Lena Biosciences Predictive toxicology. Intrinsic & idiosyncratic drug-induced liver injury. Mitochondrial toxicity in a drug metabolism-competent model.
Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Submit a Text Ad